Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis.

Although there was a trend toward reduction in need for hospitalization among the AZLI-treated patients (5% versus 14% in the placebo group), this difference did not reach statistical significance ( P = 0.064). 36 In this study, the majority of patients were adults (mean age 29.6 years) and had moderate lung disease (mean FEV 1 54% of predicted).

also in 111,027 other papers